A broad spectrum of IgE targeting self-antigens have been identified in above 90% of severe AD patients and high-avidity IgG autoantibodies have been proposed as potential diagnostic markers for severe AD (5, 10–12). The gene discussed is IGHE; the disease is Alzheimer disease.